Xenetic Biosciences Inc. (XBIO)
NASDAQ: XBIO
· Real-Time Price · USD
2.94
0.02 (0.51%)
At close: Aug 15, 2025, 3:04 PM
Xenetic Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.45M | 2.58M | 2.5M | 2.52M | 2.52M | 2.44M | 2.54M | 2.35M | 2.16M | 1.92M | 1.71M | 1.55M | 1.49M | 1.36M | 1.16M | 979.42K | 746.09K | 571.41K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.96K | 17.57K | 17.57K | 26.85K | 18.89K | 9.28K | 9.28K | n/a | n/a | n/a |
Gross Profit | 1.86M | 2.58M | 2.5M | 2.52M | 2.52M | 2.44M | 2.54M | 2.35M | 2.15M | 1.91M | 1.69M | 1.53M | 1.47M | 1.35M | 1.15M | 979.42K | 746.09K | 571.41K |
Operating Income | -3.27M | -3.88M | -4.2M | -4.36M | -5.01M | -4.87M | -4.52M | -4.82M | -4.52M | -6.01M | -6.72M | -7.03M | -7.56M | -6M | -5.75M | -5.09M | -14.22M | -14.08M |
Interest Income | 186.59K | 215.8K | 249.86K | 281.75K | 312.25K | 374.9K | 355.76K | 351.81K | 305.49K | 195.35K | 167.15K | 116.79K | 99.34K | 104.11K | 100.47K | 92.15K | 89.06K | 96.95K |
Pretax Income | -3.08M | -3.67M | -3.96M | -4.08M | -4.7M | -4.47M | -4.14M | -4.45M | -4.19M | -5.82M | -6.55M | -6.91M | -7.46M | -5.89M | -5.65M | -5M | -14.13M | -13.98M |
Net Income | -3.08M | -3.67M | -3.96M | -4.08M | -4.7M | -4.47M | -4.08M | -4.29M | -3.99M | -5.58M | -6.33M | -6.78M | -7.38M | -5.84M | -5.65M | -5M | -11.21M | -11.06M |
Selling & General & Admin | 2.77M | 3.24M | 3.42M | 3.66M | 3.65M | 3.47M | 3.56M | 3.47M | 3.59M | 3.67M | 3.65M | 3.77M | 3.86M | 3.72M | 3.74M | 3.65M | 3.51M | 3.4M |
Research & Development | 2.95M | 3.22M | 3.29M | 3.22M | 3.87M | 3.84M | 3.49M | 3.71M | 3.09M | 4.26M | 4.77M | 4.81M | 5.19M | 3.64M | 3.16M | 2.43M | 2.22M | 2M |
Other Expenses | n/a | n/a | n/a | 404.00 | -262 | -262 | 4.26K | 4.84K | 3.8K | 2.72K | -1.6K | 320.00 | -880 | 434.00 | 1.12K | -2.92K | 572.00 | 526.00 |
Operating Expenses | 5.71M | 6.46M | 6.7M | 6.88M | 7.53M | 7.31M | 7.06M | 7.18M | 6.68M | 7.94M | 8.42M | 8.58M | 9.04M | 7.36M | 6.91M | 6.07M | 5.72M | 5.4M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.71M | 6.46M | 6.7M | 6.88M | 7.53M | 7.31M | 7.06M | 7.18M | 6.68M | 7.94M | 8.42M | 8.58M | 9.04M | 7.36M | 6.91M | 6.07M | 5.72M | 5.4M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -58.62K | -158.5K | -202.27K | -233.12K | -226.51K | -126.63K | -82.86K | -52.01K | n/a | 2.92K | -2.92M | -2.92M |
Shares Outstanding (Basic) | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.52M | 1.52M | 1.52M | 1.27M | 1.27M | 1.27M | 1.02M | 1.02M | 851.29K | 874.63K |
Shares Outstanding (Diluted) | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.52M | 1.52M | 1.52M | 1.27M | 1.27M | 1.27M | 1.02M | 1.02M | 874.67K | 874.63K |
EPS (Basic) | -2 | -2.38 | -2.57 | -2.65 | -3.06 | -2.92 | -2.67 | -2.82 | -2.73 | -4.12 | -4.8 | -5.69 | -6.42 | -5.64 | -5.97 | -5.76 | -16.44 | -16.66 |
EPS (Diluted) | -2 | -2.38 | -2.57 | -2.65 | -3.06 | -2.92 | -2.67 | -2.82 | -2.73 | -4.12 | -4.8 | -5.69 | -6.42 | -5.61 | -5.94 | -5.73 | -16.41 | -16.66 |
EBITDA | -3.27M | -3.88M | -4.2M | -4.36M | -5.01M | -4.87M | -4.52M | -4.81M | -4.51M | -5.99M | -6.69M | -7.02M | -7.54M | -5.98M | -5.72M | -5.07M | -4.96M | -4.82M |
EBIT | -3.23M | -3.88M | -4.2M | -4.36M | -5.01M | -4.87M | -4.52M | -4.82M | -4.52M | -6.01M | -6.72M | -7.03M | -7.56M | -6M | -5.75M | -5.09M | -4.98M | -4.83M |
Depreciation & Amortization | n/a | n/a | -10.62K | -18.47K | -10.83K | -7.98K | 15.57K | 41.62K | 41.93K | 48.69K | 45.24K | 36.33K | 37.41K | 36.54K | 35.48K | 34.24K | 31.48K | 29.84K |